Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$0.42 - $0.68 $3,719 - $6,022
8,856 Added 38.7%
31,737 $13,000
Q1 2023

May 12, 2023

BUY
$0.56 - $1.07 $342 - $654
612 Added 2.75%
22,881 $14,000
Q4 2022

Feb 10, 2023

BUY
$0.58 - $17.99 $8,249 - $255,871
14,223 Added 176.77%
22,269 $16,000
Q3 2022

Nov 14, 2022

BUY
$0.91 - $14.63 $2,556 - $41,095
2,809 Added 53.64%
8,046 $8,000
Q2 2022

Aug 10, 2022

BUY
$0.89 - $2.47 $273 - $758
307 Added 6.23%
5,237 $6,000
Q1 2022

May 04, 2022

BUY
$1.63 - $2.55 $101 - $158
62 Added 1.27%
4,930 $12,000
Q3 2021

Nov 05, 2021

BUY
$2.45 - $4.1 $6,524 - $10,918
2,663 Added 120.77%
4,868 $15,000
Q2 2021

Aug 02, 2021

BUY
$3.0 - $4.39 $2,610 - $3,819
870 Added 65.17%
2,205 $9,000
Q1 2021

May 13, 2021

SELL
$2.2 - $5.05 $1,335 - $3,065
-607 Reduced 31.26%
1,335 $5,000
Q4 2020

Feb 10, 2021

BUY
$1.85 - $2.54 $991 - $1,361
536 Added 38.12%
1,942 $4,000
Q3 2020

Nov 12, 2020

BUY
$1.85 - $2.57 $2,601 - $3,613
1,406 New
1,406 $3,000
Q2 2020

Aug 14, 2020

SELL
$1.59 - $2.51 $675 - $1,066
-425 Closed
0 $0
Q1 2020

May 18, 2020

BUY
$1.39 - $3.19 $590 - $1,355
425 New
425 $1,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $99.7M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.